BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
1 clinical trials · Condition
◉ Watch BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer (NCT05019534) | West China Hospital | 2021-08-15 |
Track BRAF V600E-mutated /MSS Metastatic Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.